West Pharmaceutical Services will implement a restructuring plan for its Tech Group segment. The restructuring “addresses the recent reduction in business due to changes in customers’ marketing plans by reducing the operating costs and increasing the manufacturing efficiency of the segment,” according to a West statement. The unit was involved in manufacturing the delivery device for Exubera, a product that Pfizer abandoned in October. The company will reduce spending throug...